Alkermes plc (ALKS)

Alkermes (ALKS) Q3 2015 Results - Earnings Call Webcast
Feb. 24, 2015 | Price: Free! | Source: Seeking Alpha

Alkermes' (ALKS) CEO Rich Pops on Q4 2014 Results - Earnings Call Transcript
Feb. 24, 2015 | Price: Free! | Source: Seeking Alpha

Alkermes' (ALKS) CEO Rich Pops on Q3 2014 Results - Earnings Call Transcript
Oct. 29, 2014 | Price: Free! | Source: Seeking Alpha

Alkermes (ALKS) Q2 2015 Results - Earnings Call Webcast
Oct. 29, 2014 | Price: Free! | Source: Seeking Alpha

Alkermes' (ALKS) CEO Richard Pops on Q2 2014 Results - Earnings Call Transcript
July 31, 2014 | Price: Free! | Source: Seeking Alpha

Q1 2014 Alkermes Inc Earnings Conference Call (Webcast)
July 31, 2014 | Price: Free! | Source: Seeking Alpha

Alkermes plc Discusses Q4 2014 Results (Webcast)
April 30, 2014 | Price: Free! | Source: Seeking Alpha

Alkermes' CEO Discusses Q1 2014 Results - Earnings Call Transcript
April 30, 2014 | Price: Free! | Source: Seeking Alpha

Alkermes, Inc. Discusses Q3 2014 Results (Webcast)
Feb. 27, 2014 | Price: Free! | Source: Seeking Alpha

Alkermes' CEO Discusses Quarter Ended December 31, 2013 Results - Earnings Call Transcript
Feb. 27, 2014 | Price: Free! | Source: Seeking Alpha

Alkermes' CEO Presents at Credit Suisse 2013 Healthcare Conference (Transcript)
Nov. 13, 2013 | Price: Free! | Source: Seeking Alpha

Alkermes plc at Credit Suisse 2013 Healthcare Conference Transcript
Nov. 12, 2013 | Price: $106.00 | Source: Thomson

Alkermes' CEO Discusses Q3 2013 Results - Earnings Call Transcript
Oct. 31, 2013 | Price: Free! | Source: Seeking Alpha

Alkermes plc Quarter Ended September 30, 2013 Earnings Conference Call Transcript
Oct. 31, 2013 | Price: $106.00 | Source: Thomson

Alkermes PLC Q2 2014
Oct. 31, 2013 | Price: Free! | Source: Morningstar

Alkermes, Inc. Discusses Q2 2013 Results (Webcast)
Oct. 31, 2013 | Price: Free! | Source: Seeking Alpha

Alkermes' CEO Presents at Morgan Stanley Healthcare Conference - (Transcript)
Sept. 9, 2013 | Price: Free! | Source: Seeking Alpha

Alkermes plc at Morgan Stanley Healthcare Conference Transcript
Sept. 9, 2013 | Price: $106.00 | Source: Thomson

Alkermes PLC(ALKS) Q1 2014 Earnings Call Transcript
July 25, 2013 | Price: Free! | Source: Morningstar

Alkermes Plc (ALKS) CEO Discusses F1Q14 Results - Earnings Call Transcript
July 25, 2013 | Price: Free! | Source: Seeking Alpha

Alkermes plc Quarter Ended June 30, 2013 Earnings Conference Call Transcript
July 25, 2013 | Price: $106.00 | Source: Thomson

Alkermes Inc.'s CEO Presents at R&D Day - Transcript
July 19, 2013 | Price: Free! | Source: Seeking Alpha

Alkermes R&D Day 2013 Transcript
July 17, 2013 | Price: $106.00 | Source: Thomson

Alkermes' CEO Presents at Goldman Sachs Healthcare Conference (Transcript)
June 13, 2013 | Price: Free! | Source: Seeking Alpha

Alkermes plc at Goldman Sachs Healthcare Conference Transcript
June 11, 2013 | Price: $106.00 | Source: Thomson

Alkermes plc at Jefferies Global Healthcare Conference Transcript
June 3, 2013 | Price: $106.00 | Source: Thomson

Alkermes' Management Presents at Deutsche Bank 38th Annual dbAccess Health Care Conference (Transcr
May 29, 2013 | Price: Free! | Source: Seeking Alpha

Alkermes plc at 38th Annual dbAccess Health Care Conference Transcript
May 29, 2013 | Price: $106.00 | Source: Thomson

Alkermes' CEO Discusses F4Q13 Results - Earnings Call Transcript
May 23, 2013 | Price: Free! | Source: Seeking Alpha

Alkermes PLC Q4 2013
May 23, 2013 | Price: Free! | Source: Morningstar

Alkermes plc Q4 2013 Earnings Conference Call Transcript
May 23, 2013 | Price: $106.00 | Source: Thomson

Alkermes' CEO Presents at Bank of America Merrill Lynch Smid Cap Conference (Transcript)
May 8, 2013 | Price: Free! | Source: Seeking Alpha

Alkermes plc at Bank of America Merrill Lynch Smid Cap Conference Transcript
May 8, 2013 | Price: $106.00 | Source: Thomson

Alkermes plc at Cowen Health Care Conference Transcript
March 4, 2013 | Price: $106.00 | Source: Thomson

Alkermes plc at RBC Capital Markets\' Healthcare Conference Transcript
Feb. 26, 2013 | Price: $106.00 | Source: Thomson

Alkermes CEO Presents at Citi Global Helathcare Conference (Transcript)
Feb. 25, 2013 | Price: Free! | Source: Seeking Alpha

Alkermes plc at Citi Global Healthcare Conference Transcript
Feb. 25, 2013 | Price: $106.00 | Source: Thomson

Alkermes plc at Leerink Swann Global Healthcare Conference Transcript
Feb. 13, 2013 | Price: $106.00 | Source: Thomson

Alkermes plc at BIO CEO & Investor Conference Transcript
Feb. 12, 2013 | Price: $106.00 | Source: Thomson

Alkermes plc Q3 2013 Earnings Conference Call Transcript
Jan. 31, 2013 | Price: $106.00 | Source: Thomson

Alkermes PLC(ALKS) Q3 2013 Earnings Call Transcript
Jan. 31, 2013 | Price: Free! | Source: Morningstar

Alkermes' CEO Discusses F3Q2013 (Qtr End 12/31/12)Results - Earnings Call Transcript
Jan. 31, 2013 | Price: Free! | Source: Seeking Alpha

Alkermes' CEO Presents at J.P. Morgan Healthcare Conference (Transcript)
Jan. 8, 2013 | Price: Free! | Source: Seeking Alpha

Alkermes plc at JPMorgan Global Healthcare Conference Transcript
Jan. 8, 2013 | Price: $106.00 | Source: Thomson

Alkermes' Management Presents at Credit Suisse 2012 Healthcare Conference (Transcript)
Nov. 14, 2012 | Price: Free! | Source: Seeking Alpha

Alkermes plc at Jefferies Global Healthcare Conference Transcript
Nov. 14, 2012 | Price: $106.00 | Source: Thomson

Alkermes plc at Credit Suisse Group AG Healthcare Conference Transcript
Nov. 14, 2012 | Price: $106.00 | Source: Thomson

Q2 FY 2013 Alkermes plc Earnings Conference Call Transcript
Nov. 1, 2012 | Price: $106.00 | Source: Thomson

Alkermes PLC(ALKS) Q2 2013 Earnings Call Transcript
Nov. 1, 2012 | Price: Free! | Source: Morningstar

Alkermes' CEO Discusses F2Q13 Results - Earnings Call Transcript
Nov. 1, 2012 | Price: Free! | Source: Seeking Alpha

Alkermes' CEO Presents at Morgan Stanley Global Healthcare Conference (Transcript)
Sept. 11, 2012 | Price: Free! | Source: Seeking Alpha

Alkermes plc at Morgan Stanley Healthcare Conference Transcript
Sept. 11, 2012 | Price: $54.00 | Source: Thomson

Alkermes plc at Robert W Baird\'s Health Care Conference Transcript
Sept. 6, 2012 | Price: $54.00 | Source: Thomson

Alkermes' CEO Discusses F1Q13 Results - Earnings Call Transcript
July 26, 2012 | Price: Free! | Source: Seeking Alpha

Alkermes PLC(ALKS) Q1 2013 Earnings Call Transcript
July 26, 2012 | Price: Free! | Source: Morningstar

Alkermes plc Q1 2013 Earnings Conference Call Transcript
July 26, 2012 | Price: $54.00 | Source: Thomson

Alkermes PLC(ALKS) Q4 2012 Earnings Call Transcript
May 17, 2012 | Price: Free! | Source: Morningstar

Alkermes PLC(ALKS) Q3 2012 Earnings Call Transcript
Feb. 2, 2012 | Price: Free! | Source: Morningstar

Alkermes PLC(ALKS) Q2 2012 Earnings Call Transcript
Nov. 3, 2011 | Price: Free! | Source: Morningstar

Alkermes CEO Discusses F2Q2011 Results - Earnings Call Transcript
Nov. 7, 2010 | Price: Free! | Source: Seeking Alpha

Alkermes Q1 2011 Earnings Conference Call Transcript
Aug. 6, 2010 | Price: Free! | Source: Seeking Alpha

Alkermes Inc. F4Q10 (Qtr End 03/31/10) Earnings Call Transcript
May 13, 2010 | Price: Free! | Source: Seeking Alpha

Alkermes, Inc. F3Q10 (Qtr End 12/31/09) Earnings Call Transcript
Feb. 4, 2010 | Price: Free! | Source: Seeking Alpha

Alkermes, Inc. Q3 2009 Earnings Call Transcript
Feb. 17, 2009 | Price: Free! | Source: Seeking Alpha

Alkermes, Inc. F2Q09 (Qtr End 09/30/08) Earnings Call Transcript
Nov. 18, 2008 | Price: Free! | Source: Seeking Alpha

Alkermes, Inc F1Q09 (Qtr End 06/30/08) Earnings Call Transcript
Aug. 7, 2008 | Price: Free! | Source: Seeking Alpha

Alkermes Inc. F408 (Qtr End 03/31/2008) Earnings Call Transcript
May 22, 2008 | Price: Free! | Source: Seeking Alpha

Alkermes Inc., F3Q08 (Qtr End 12/31/07) Earnings Call Transcript
Feb. 10, 2008 | Price: Free! | Source: Seeking Alpha

Recent filings

Statement of changes in beneficial ownership of securities - Feb. 27, 2015

SVP of Alkermes plc was just granted 54,500 options and restricted shares - Feb. 27, 2015

Director and CEO of Alkermes plc was just granted 240,000 options and restricted shares - Feb. 27, 2015

Alkermes plc's Chief Commercial Officer was just granted 54,500 options and restricted shares - Feb. 27, 2015

Statement of changes in beneficial ownership of securities - Feb. 27, 2015

SVP of Alkermes plc was just granted 64,500 options and restricted shares - Feb. 27, 2015

EVP of Alkermes plc was just granted 77,500 options and restricted shares - Feb. 27, 2015

SVP & CFO of Alkermes plc was just granted 54,500 options and restricted shares - Feb. 27, 2015

Alkermes plc Just Filed Its Annual Report: (Loss) Earnings P... - Feb. 24, 2015

Current report, items 2.02 and 9.01 - Feb. 24, 2015

President of Alkermes plc just cashed-in 18,000 options - Feb. 23, 2015

Statement of changes in beneficial ownership of securities - Feb. 18, 2015

Statement of acquisition of beneficial ownership by individuals - Feb. 13, 2015

Statement of acquisition of beneficial ownership by individuals - Feb. 11, 2015

Statement of acquisition of beneficial ownership by individuals - Feb. 10, 2015

SVP of Alkermes plc just cashed-in 15,000 options - Feb. 4, 2015

Alkermes plc director just cashed-in 5,000 options - Feb. 4, 2015

SVP & CFO of Alkermes plc just cashed-in 10,000 options - Feb. 4, 2015

SVP of Alkermes plc just disposed of 1,800 shares - Jan. 27, 2015

SVP of Alkermes plc just cashed-in 46,321 options - Jan. 27, 2015

Sorry, no schedule available for this company

OwnerSharesAs Of
1. FMR LLC 21,874,183 Sept. 30, 2014
2. WELLINGTON MANAGEMENT CO LLP 20,442,699 Dec. 31, 2014
3. PRICE T ROWE ASSOCIATES INC /MD/ 16,184,068 Dec. 31, 2014
4. Invesco Ltd. 11,749,024 Dec. 31, 2014
5. Invesco Ltd. 9,919,821 Sept. 30, 2014
6. VANGUARD GROUP INC 8,683,149 Sept. 30, 2014
7. TIAA CREF INVESTMENT MANAGEMENT LLC 4,584,508 Dec. 31, 2014
8. FRANKLIN RESOURCES INC 4,450,190 Sept. 30, 2014
9. BlackRock Institutional Trust Company, N.A. 3,526,212 Dec. 31, 2014
10. FRONTIER CAPITAL MANAGEMENT CO LLC 3,324,009 Dec. 31, 2014
11. FEDERATED INVESTORS INC /PA/ 3,045,700 Dec. 31, 2014
12. BlackRock Fund Advisors 2,928,044 Sept. 30, 2014
13. WELLS FARGO & COMPANY/MN 2,136,461 Sept. 30, 2014
14. BlackRock Group LTD 2,054,105 Sept. 30, 2014
15. WELLS FARGO & COMPANY/MN 2,036,701 Dec. 31, 2014
16. Clearbridge Investments, LLC 2,004,324 Dec. 31, 2014
17. WADDELL & REED FINANCIAL INC 1,910,032 Dec. 31, 2014
18. State Street Corp 1,811,578 Dec. 31, 2014
19. BlackRock Group LTD 1,484,007 Dec. 31, 2014
20. BlackRock Advisors LLC 1,443,581 Dec. 31, 2014
21. TEACHERS ADVISORS INC 1,409,355 Dec. 31, 2014
22. GOLDMAN SACHS GROUP INC 1,393,276 Dec. 31, 2014
23. Bank of New York Mellon Corp 1,344,172 Sept. 30, 2014
24. Bank of New York Mellon Corp 1,344,172 Sept. 30, 2014
25. DEUTSCHE BANK AG\ 1,182,511 Dec. 31, 2014
26. Bank of New York Mellon Corp 1,157,702 Dec. 31, 2014
27. Ameriprise Financial Inc 1,149,130 Dec. 31, 2014
28. UBS GLOBAL ASSET MANAGEMENT AMERICAS INC 1,093,489 Dec. 31, 2014
29. DEUTSCHE BANK AG\ 1,034,832 Sept. 30, 2014
30. Meditor Group Ltd 1,030,639 Dec. 31, 2014
 


Feedback